An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Learn how to use Google Flow to create and edit AI images and videos with Veo 3.1, Nano Banana 2, and Gemini. This tutorial covers pricing, credits, image generation, AI video creation, camera ...